- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00580567
Impulsivity in Pathological Gambling
Impulsivity in Pathological Gambling: A Cross Sectional Analysis on Tests of Impulsivity Between Pathological Gamblers and a Non-pathological Control Group.
The purpose of the this study is to compare pathological gamblers versus non-pathological gamblers using tests that measure different components of impulsivity. We aim to invite a total of 120 individuals to participate in this study.
Impulsivity has been described as the cognitive inability to delay gratification, a failure to inhibit behavioral action or acting without forethought about consequences. Impulsivity has also been seen as a personality trait characterized by risk-taking or sensation seeking behavior. Pathological gamblers demonstrate aspects of impulsivity; they act without thinking, have difficult inhibiting urges to gamble and desire immediate gratification. The goal of this project is to clarify which components of impulsivity are associated with pathological gambling. Non-treatment seeking, pathological gamblers and controls will be recruited from the community and local casinos. Each participant will be administered a battery of tests that represent different operational definitions of impulsivity.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
California
-
Los Angeles, California, États-Unis, 90095
- UCLA Neuropsychiatric Institute
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
Inclusion Criteria for Pathological Gamblers:
- 18 years or older
- Be able to speak, read and write in English
- Current diagnosis of pathological gambling (using DSM-IV criteria)
- South Oaks Gambling Screen (SOGS) score of 5 or above during screening
- Recent gambling activity -- at least once within one week prior to enrollment.
- Voluntarily given informed consent and signed the informed consent document.
- Not currently seeking treatment for gambling
Inclusion Criteria For Control Participants:
- 18 years or older
- Be able to speak, read and write in English
- South Oaks Gambling Screen (SOGS) score of 5 or less during screening
- Voluntarily given informed consent and signed the informed consent document
- Does not meet diagnosis of pathological gambling by DSM-IV criteria
- Not currently seeking treatment for gambling
Exclusion Criteria:
Exclusion Criteria for all participants:
- Current treatment for pathological gambling, excluding involvement with Gamblers Anonymous
- Ongoing medication for any psychiatric disorders, including anti-psychotics, antidepressants, mood stabilizers, anxiolytics or sedative/hypnotics.
- Dependence by DSM-IV criteria on any psychoactive substance, excluding caffeine or nicotine
- Presence of clinically unstable medical disorders that could harm the subject if not treated immediately.
- Presence of any neurological or psychiatric disorders (as assessed by the SCID or MINI and BDI-II) that would require immediate treatment.
- Test positive urine toxicology for illicit drugs prior to enrollment
- Hamilton Depression Scale score of >17
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
---|
1
Pathological Gamblers
|
2
Non-Pathological Gamblers
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Barratt Impusivity Scale
Délai: 12 months
|
12 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Timothy W. Fong, M.D., UCLA Gambling Studies Program
Publications et liens utiles
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- PA-00-004
- K23DA019522 (Subvention/contrat des NIH des États-Unis)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .